Variant report
Variant | nsv1027755 |
---|---|
Chromosome Location | chr8:5244868-5264654 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185569103 | chr8:5247609-5247610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75929157 | chr8:5247611-5247612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547493827 | chr8:5247627-5247628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190402980 | chr8:5247649-5247650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191127660 | chr8:5247654-5247655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542892159 | chr8:5247671-5247672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528499055 | chr8:5247675-5247676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528809070 | chr8:5247682-5247683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183593476 | chr8:5247691-5247692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540941567 | chr8:5247719-5247720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368036893 | chr8:5247720-5247721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575740736 | chr8:5247726-5247727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6983746 | chr8:5247731-5247732 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs142765038 | chr8:5247750-5247751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569418828 | chr8:5247759-5247760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529891789 | chr8:5247769-5247770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548120741 | chr8:5247800-5247801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188338431 | chr8:5247805-5247806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533818838 | chr8:5247815-5247816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6982657 | chr8:5247816-5247817 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs570073784 | chr8:5247823-5247824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537452186 | chr8:5247870-5247871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181128090 | chr8:5247873-5247874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574226528 | chr8:5247881-5247882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536831260 | chr8:5247888-5247889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554835081 | chr8:5247911-5247912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550444652 | chr8:5247933-5247934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139790390 | chr8:5247979-5247980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186501823 | chr8:5247984-5247985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565578629 | chr8:5247994-5247995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190113284 | chr8:5248001-5248002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116215637 | chr8:5248043-5248044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149790720 | chr8:5248044-5248045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181813457 | chr8:5248089-5248090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548686380 | chr8:5248097-5248098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560057433 | chr8:5248119-5248120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6984369 | chr8:5248126-5248127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570158999 | chr8:5248131-5248132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs80337013 | chr8:5248156-5248157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187215178 | chr8:5248170-5248171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549393404 | chr8:5248221-5248222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568068160 | chr8:5248237-5248238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535165828 | chr8:5248249-5248250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553839509 | chr8:5248260-5248261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376793542 | chr8:5248292-5248293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552611235 | chr8:5248301-5248302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573306910 | chr8:5248304-5248305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534439392 | chr8:5248319-5248320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10866988 | chr8:5248337-5248338 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs559282163 | chr8:5248340-5248341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Medulloblastoma | 16783165 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5247600-5248600 | Enhancers | Fetal Brain Male | brain |
2 | chr8:5247800-5248200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr8:5247800-5248400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr8:5248000-5248400 | Enhancers | Fetal Brain Female | brain |
5 | chr8:5248000-5248400 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr8:5257200-5258800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr8:5257800-5258000 | Enhancers | Brain Germinal Matrix | brain |
8 | chr8:5258600-5258800 | Enhancers | Brain Germinal Matrix | brain |